List of Oral Presentations


The following Oral Presentations will be delivered at BIOINFOMICs 2018:

Drug Development and Biomarker Discovery in Cancer  
Speaker Title Institution Country
Gerardo E. Guillén, PhD. Pending Title Center for Genetic Engineering and Biotechnology, CIGB Cuba
Mihalis I. Panagiotidis, BSc, MSc, PhD  Nutriepigenomics in Cancer Development Department of Applied Sciences, Faculty of Health & Life Sciences, Northumbria University, Newcastle UK
Integration of OMICs to Develop Personalized Medicines
Speaker Title Institution Country
Prof. K. K. Jain MD, FRACS, FFPM Integration and translation of OMICs technologies (genomics, proteomis, metabolomics, etc) using systems biology approach to develop personalized medicines (from discovery to clinical applications). Jain PharmaBiotech
Prof. Du Toit Loots - PhD TB or not TB: New metabolomics biomarkers better characterizing and diagnosing tuberculosis. Human Metabolomics
North-West University,
South Africa
South Africa
Walter Bottje Ph.D Exploiting proteogenomics to reveal cellular mechanisms of efficiency Department of Poultry Science, University of Arkansas, Fayetteville, AR, USA. EE.UU
Dr. Susmita Datta Advances and Challenges of Single Cell RNA Sequencing Data Analysis Professor, Co-Director of Biostatistics and Epidemiology Research Design (CTSI);
Tenured Professor and Preeminent Hire Department of Biostatistics;
College of Public Health & Health Professions and College of Medicine
University of Florida
Prof. Vladimir Havlicek, PhD Imaging mass spectrometry and microbial metabolomics on track of infectious diseases Institute of Microbiology
Prague, Czech Republic
  Dr Beatriz Mancheco Teruel Cuba: the history of admixture and population structure using genome-wide data National Center of Medical Genetics, Havana, Cuba Cuba
  Dr. Chottova Dvorakova M Past and present of laser capture microdissection application in intracardiac nervous system research Dpt. of Physiology, and Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Czech Republic Czech
James Bain, PhD Insights from Metabolomics in the International “Hyperglycemia and Adverse Pregnancy Outcome” (HAPO) study. Faculty Member, Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center EE.UU
Haiyan Fu, PhD Biomarker potential of serum metabolomics profiles for Mucopolysaccharidosis III Center for Gene Therapy, Research Institute at Nationwide Children’s Hospital, Columbus, OH EE.UU
Stanislav N.Naryzhny, D.Sc., Ph.D. Variety of proteoforms in cancer cells Petersburg Nuclear Physics Institute NRC "Kurchatov Institute", Leningrad district, Gatchina, 188300, Russia Rusia
Dr Masood Kamali Moghaddam Advanced Molecular Tools for Proteome Analyses and Diagnostics Department of Immunology, Genetics and Pathology.Uppsala University. Sweden
Biomarkers and Drugs in Ataxia and Others Neurodegenerative Diseases
Speaker Title Institution Country
Prof. DrSc. Luis Velázquez Pérez, PhD Biomarkers, Precision Medicine and early intervention in Spinocerebellar Ataxias Senior Academic of the Cuban Academy of Sciences President of the Cuban Academy of Sciences Cuba
Dr. Giselle Pentón-Rol Modulation of genes for the combination phycocyanobilin and ifn beta promises greater expectations for a new therapy for multiple sclerosis Center for Genetic Engineering and Biotechnology, CIGB Cuba
Elizabeth CM de Lange, PhD Using metabolomics for modelling multiple harmacokinetic/pharmacodynamic response patterns in pharmacometabolomics to reveal system wide effects of CNS drugs Systems Biomedicine & Pharmacology
Leiden University, NL
Dr. María Elena Fdz de Cossio HLA alleles and TNF promotor genes polymorphism  among Cuban patients group with MS and NMO Center for Genetic Engineering and Biotechnology, CIGB Cuba
Dr.C. Luis Almaguer Mederos Massive analysis of cDNA ends applications to ataxin-2 knockout mice Center for Research and Rehabilitation of Hereditary Ataxias. Holguin, Cuba Cuba
Prof. Georg Auburger Metabolome and lipid profile of SCA2 brain tissue in Atxn2-CAG100-KnockIn mice and in a patient Exp. Neurology, Goethe University Frankfurt am Main Germany